Fungal Endocarditis Companies

ID: MRFR/LS/3679-HCR

85 Pages

Vikita Thakur

Last Updated: February 16, 2025

Fungal endocarditis is a rare but serious condition involving the inflammation of the heart lining caused by a fungal infection. Managing fungal endocarditis often requires a combination of antifungal medications and sometimes surgical intervention. There might not be specific companies solely dedicated to fungal endocarditis treatment, but pharmaceutical companies involved in antifungal drug development may play a role.

Fungal Endocarditis Market

Market Size

Forecast Period2025 - 2035

CAGR (2025 - 2035)5.26%

2024 Market Size$ 364.25 Million

2025 Market Size$ 387.58 Million

2035 Market Size$ 642.97 Million

Key Players

Pfizer Inc

Merck & Co Inc

AstraZeneca PLC

Gilead Sciences Inc

Bristol-Myers Squibb Company

Novartis AG

Trends

Rising Incidence of Fungal Infections
Advancements in Diagnostic Technologies
Development of Novel Therapeutics

Opportunities

Rising Incidence of Fungal Infections

Summary Table of Contents Segmentation Download PDF

Customize Report

Certified Researchers

Top Industry Leaders in the Fungal Endocarditis Market

Latest Fungal Endocarditis Companies Updates:

Amplyx Pharmaceuticals Initiates Phase 3 Trial for APX800:This promising antifungal drug candidate specifically targets Candida and Aspergillus species, common culprits in FE. Positive results could significantly impact the market.

Roche Receives FDA Breakthrough Therapy Designation for Isavuconazole:This designation for Isavuconazole, an existing antifungal drug, highlights its potential efficacy in treating FE, potentially expanding its use and increasing market share for Roche.

Mesa Labs Collaborates with University of Pittsburgh:The collaboration aims to develop a rapid diagnostic test for FE using a novel blood biomarker. Early detection could significantly improve patient outcomes and decrease healthcare costs.

List of Fungal Endocarditis Key companies in the market:

Pfizer
Merck & Co.
Sanofi
Astellas Pharma, Inc.
GlaxoSmithKline plc
Novartis AG
Enzon Pharmaceuticals, Inc.
Bayer AG
Sigma-Aldrich
Abbott Laboratories

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”